anti-IL1 beta antibody product blog
Tags: Antibody; Monoclonal Antibody; IL1 beta; anti-IL1 beta antibody;
The IL1 beta n/a (Catalog #MBS834753) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s IL1 beta can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunoprecipitation (IP), Immunohistochemistry (IHC).ELISA: 1:10,000. Researchers should empirically determine the suitability of the IL1 beta n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal IL1 beta antibody (FITC).
Biological Significance: IL1 beta is a proinflammatory cytokine produced in a variety of cells including monocytes, tissue macrophages, keratinocytes and other epithelial cells. Both IL1a and IL1beta binds to the same receptor and has similar if not identical biological properties. These cytokines have a broad range of activities including, stimulation of thymocyte proliferation, by inducing IL2 release, B-cell maturation and proliferation, mitogenic FGFlike activity and the ability to stimulate the release of prostaglandin and collagenase from synovial cells. Tag/Conjugate: FITC
Immunogen: IL1 beta antibody (FITC) was raised in Mouse using recombinant human IL-1beta as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IL1 beta are readily searchable from our website. Different antibodies against the same target such as IL1 beta may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.